Trials / Completed
CompletedNCT01030159
National Cancer Institute Thai Cancer Anemia Survey
Anemia Survey in Cancer Patients Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Janssen-Cilag Ltd.,Thailand · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.
Detailed description
Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adult Cancer Patients | Tracking anemia management in Adult Cancer Patients |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2009-12-11
- Last updated
- 2014-04-09
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01030159. Inclusion in this directory is not an endorsement.